Cases & Deals

Pfizer acquires Coley Pharmaceutical Group, Inc. for a total value of $164 million

Clients Pfizer, Inc.

Jones Day represented Pfizer, Inc. in its acquisition of Coley Pharmaceutical Group, Inc. , a publicly-held biopharmaceutical company based in Wellesley, Massachusetts, specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.